Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive subconjunctival mitomycin C in glaucoma triple procedure

D H Shin1, P A Simone, M S Song

  • 1Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI 48201-1423, USA.

Ophthalmology
|October 1, 1995
PubMed
Summary

Adding subconjunctival mitomycin C to glaucoma surgery did not improve final intraocular pressure. This study found no significant benefit of adjunctive mitomycin C in primary open-angle glaucoma patients undergoing combined procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The distinctive P450 oxidoreductase (PORD) urinary steroid metabolome in the first week of life: Report of three cases with severe disorder.

The Journal of steroid biochemistry and molecular biology·2025
Same author

Plastic physicians: The surgical salamanders of the COVID-19 pandemic.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2020
Same author

Response to - 'Managing hand trauma during the COVID-19 pandemic using a one-stop clinic'.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2020
Same author

The use of Whatsapp<sup>Ⓡ</sup> as a way to deliver plastic surgery teaching during the COVID-19 pandemic.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2020
Same author

Cortisol metabolism, postnatal depression and weight changes in the first 12 months postpartum.

Clinical endocrinology·2016
Same author

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.

Oncogene·2009

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Innovation

Background:

  • Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
  • Trabeculectomy combined with cataract surgery is a common treatment for glaucoma and cataracts.
  • Mitomycin C is an antifibrotic agent sometimes used to enhance glaucoma surgery outcomes.

Purpose of the Study:

  • To assess the efficacy of adjunctive subconjunctival mitomycin C in POAG patients.
  • To evaluate its impact on intraocular pressure (IOP) after combined trabeculectomy and cataract surgery.

Main Methods:

  • 78 POAG patients undergoing combined surgery were randomized.
  • Groups received either no mitomycin C or subconjunctival application of 0.5 mg/ml mitomycin C for 1, 3, or 5 minutes.

Related Experiment Videos

  • Intraocular pressure, medication use, and visual acuity were monitored over a mean follow-up of 21 months.

    • Main Results:

    • All groups showed significant IOP reduction compared to preoperative levels.
    • No significant differences in IOP, medication requirements, or visual acuity were observed among the four groups.
    • Adjunctive mitomycin C did not provide additional IOP lowering benefits compared to the control group.

    Conclusions:

    • Subconjunctival mitomycin C did not enhance the surgical outcomes of primary trabeculectomy combined with phacoemulsification and IOL implantation in POAG.
    • Further research is needed to determine the specific role of mitomycin C in complex glaucoma triple procedures.